Katsuyoshi Ando

Probiotic‑derived ferrichrome inhibits the growth of refractory pancreatic cancer cells

Akemi Kita, Mikihiro Fujiya, Hiroaki Konishi et al. · International Journal of Oncology · 2020 · 64 citations · Full text

Medicine, Oncology, Pharmacology +16

Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication

Hiroki Tanabe, Keiichi Yoshino, Katsuyoshi Ando et al. · Annals of Clinical Microbiology and Antimicrobials · 2018 · 49 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Probiotic‐Derived Polyphosphate Accelerates Intestinal Epithelia Wound Healing through Inducing Platelet‐Derived Mediators

Shotaro Isozaki, Hiroaki Konishi, Mikihiro Fujiya et al. · Mediators of Inflammation · 2021 · 39 citations · Full text

Life Sciences, Immunology, Pathobiology +17

Probiotic Aspergillus oryzae produces anti-tumor mediator and exerts anti-tumor effects in pancreatic cancer through the p38 MAPK signaling pathway

Hiroaki Konishi, Shotaro Isozaki, Shin Kashima et al. · Scientific Reports · 2021 · 39 citations · Full text

Medicine, Cancer Biology, Oncology +11

The incidence and risk factors of venous thromboembolism in Japanese inpatients with inflammatory bowel disease: a retrospective cohort study

Katsuyoshi Ando, Mikihiro Fujiya, Yoshiki Nomura et al. · Intestinal Research · 2018 · 35 citations · Full text

Medicine, Hematology, Clinical Epidemiology +13